TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 07, 2024 07:50 ET
|
TG Therapeutics, Inc.
NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the...
Form 8.3 - Keywords Studios Plc
June 07, 2024 07:47 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Form 8.3 - Balanced Commercial Property Trust Limited
June 07, 2024 07:42 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
June 07, 2024 07:41 ET
|
Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of...
Form 8.3 - Alpha Financial Markets Consulting Plc
June 07, 2024 07:40 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Falco Announces Brokered Private Placement for Gross Proceeds of Up to C$5.0 Million
June 07, 2024 07:40 ET
|
Falco Resources Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, June 07, 2024 (GLOBE NEWSWIRE) -- Falco Resources Ltd. (TSX-V: FPC) ("Falco" or the...
TECVAYLI®▼ (teclistamab) muestra respuestas sostenidas profundas y duraderas en pacientes con mieloma múltiple en recaída o refractario
June 07, 2024 07:31 ET
|
Janssen Cilag International NV
Los datos más recientes de MajesTEC-1 muestran una mediana de duración de la respuesta de 24 meses, con respuestas cada vez más profundas, incluso en los pacientes que se pasaron a la dosificación...
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
June 07, 2024 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
EverWind Fuels Unveils New Site Renderings for Its Green Hydrogen and Ammonia Production Facility in Newfoundland & Labrador
June 07, 2024 07:30 ET
|
EverWind Fuels
ST. JOHN'S, Newfoundland & Labrador, June 07, 2024 (GLOBE NEWSWIRE) -- EverWind Fuels ("EverWind"), North America’s leading developer of green hydrogen projects, is excited to release new...
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024 07:30 ET
|
Kura Oncology, Inc.
SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines...